Stock Events

Stock Events

Polypid 

$4.42
15
+$0.04+0.91% Today

Statistics

Day High
4.47
Day Low
4.37
52W High
5.12
52W Low
2.3
Volume
54,104
Avg. Volume
61,224
Mkt Cap
80.46M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-1.22
-0.92
-0.63
-0.33
Expected EPS
-0.433333
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-68.34MNet Income

Analyst Ratings

$11.00Average Price Target
The highest estimate is 13.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PYPD. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical and medical devices sector, directly competing with Polypid's advanced drug delivery systems.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global biopharmaceutical company that competes in the development and commercialization of medicines and vaccines, similar to Polypid's therapeutic areas.
Novartis
NVS
Mkt Cap237.61B
Novartis is a healthcare company that offers solutions in various therapeutic areas, competing with Polypid in drug delivery technologies.
Merck
MRK
Mkt Cap214.76B
Merck is known for its innovations in pharmaceuticals, directly competing with Polypid in the development of treatments for various diseases.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in the pharmaceuticals industry, focusing on innovative therapies, which puts it in direct competition with Polypid.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company focusing on human therapeutics, competing with Polypid in the biopharmaceutical sector.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company, which competes with Polypid in the development of prescription medicines.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics, in competition with Polypid.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is involved in the invention of medicines for serious medical conditions, competing with Polypid's drug delivery and formulations.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Polypid in developing and commercializing prescription medicines.

About

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Show more...
CEO
Ms. Dikla Czaczkes Akselbrad
Employees
57
Country
IL
ISIN
IL0011326795

Listings

F
DE
2PV.F
BOATS
BOATS
PYPD.BOATS
XNAS
US
PYPD

0 Comments

Share your thoughts

FAQ

What is Polypid stock price today?▼
The current price of PYPD is $4.42 USD — it has increased by +0.91% in the past 24 hours. Watch Polypid stock price performance more closely on the chart.
What is Polypid stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Polypid stocks are traded under the ticker PYPD.
Is Polypid stock price growing?▼
PYPD stock has risen by +2.45% compared to the previous week, the month change is a +3.41% rise, over the last year Polypid has showed a +59.88% increase.
What is Polypid market cap?▼
Today Polypid has the market capitalization of 80.46M
When is the next Polypid earnings date?▼
Polypid is going to release the next earnings report on May 13, 2026.
What were Polypid earnings last quarter?▼
PYPD earnings for the last quarter are -0.41 USD per share, whereas the estimation was -0.33 USD resulting in a -24.24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Polypid revenue for the last year?▼
Polypid revenue for the last year amounts to 0 USD.
What is Polypid net income for the last year?▼
PYPD net income for the last year is -68.34M USD.
How many employees does Polypid have?▼
As of April 01, 2026, the company has 57 employees.
In which sector is Polypid located?▼
Polypid operates in the Health Care sector.
When did Polypid complete a stock split?▼
The last stock split for Polypid was on September 21, 2023 with a ratio of 1:30.
Where is Polypid headquartered?▼
Polypid is headquartered in Petah Tikva, IL.